Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innovex International (INVX) EBITDA (2016 - 2025)

Innovex International (INVX) has disclosed EBITDA for 17 consecutive years, with $14.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 32.69% year-over-year to $14.3 million, compared with a TTM value of $96.2 million through Dec 2025, down 25.6%, and an annual FY2025 reading of $96.2 million, down 25.6% over the prior year.
  • EBITDA was $14.3 million for Q4 2025 at Innovex International, down from $40.5 million in the prior quarter.
  • Across five years, EBITDA topped out at $85.0 million in Q3 2024 and bottomed at -$72.2 million in Q4 2021.
  • Average EBITDA over 5 years is $4.1 million, with a median of $9.0 million recorded in 2022.
  • The sharpest move saw EBITDA crashed 539.49% in 2023, then skyrocketed 483.65% in 2024.
  • Year by year, EBITDA stood at -$72.2 million in 2021, then skyrocketed by 117.08% to $12.3 million in 2022, then plummeted by 539.49% to -$54.2 million in 2023, then soared by 139.11% to $21.2 million in 2024, then plummeted by 32.69% to $14.3 million in 2025.
  • Business Quant data shows EBITDA for INVX at $14.3 million in Q4 2025, $40.5 million in Q3 2025, and $22.1 million in Q2 2025.